Carbamazepine (CBZ) is a first generation anti-seizure drug, considered as first choice therapy in focal epilepsy but associated with cognitive side effects. Lacosamide (LCM) is a third-generation anti-seizure drug approved for treating focal epilepsy. This case series documented the comparable efficacy of LCM and CBZ as first add on treatments in patients affected by uncontrolled focal seizures. LCM showed an increase in EpiTrack scores, which measure cognitive abilities, at follow-up compared to CBZ. This preliminary data may represent the basis for future prospective studies aimed at comparing the long-term cognitive side effects of LCM and CBZ. (C) 2018 The Authors. Published by Elsevier Inc.
Liguori, C., Izzi, F., Manfredi, N., Mercuri, N.b., Placidi, F. (2018). Lacosamide may improve cognition in patients with focal epilepsy: EpiTrack to compare cognitive side effects of lacosamide and carbamazepine. EPILEPSY & BEHAVIOR CASE REPORTS, 10, 35-37 [10.1016/j.ebcr.2018.02.004].
Lacosamide may improve cognition in patients with focal epilepsy: EpiTrack to compare cognitive side effects of lacosamide and carbamazepine
Liguori C.;Izzi F.;Mercuri N. B.;Placidi F.
2018-01-01
Abstract
Carbamazepine (CBZ) is a first generation anti-seizure drug, considered as first choice therapy in focal epilepsy but associated with cognitive side effects. Lacosamide (LCM) is a third-generation anti-seizure drug approved for treating focal epilepsy. This case series documented the comparable efficacy of LCM and CBZ as first add on treatments in patients affected by uncontrolled focal seizures. LCM showed an increase in EpiTrack scores, which measure cognitive abilities, at follow-up compared to CBZ. This preliminary data may represent the basis for future prospective studies aimed at comparing the long-term cognitive side effects of LCM and CBZ. (C) 2018 The Authors. Published by Elsevier Inc.| File | Dimensione | Formato | |
|---|---|---|---|
|
Lacosamide may improve cognition 2018.pdf
accesso aperto
Licenza:
Copyright dell'editore
Dimensione
388.28 kB
Formato
Adobe PDF
|
388.28 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
